The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.85
Bid: 32.85
Ask: 33.05
Change: 2.50 (8.24%)
Spread: 0.20 (0.609%)
Open: 30.90
High: 33.80
Low: 30.65
Prev. Close: 30.35
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 -Marston's plc

10 Feb 2021 14:23

RNS Number : 6629O
State Street Global Advisors
10 February 2021
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

State Street Global Advisors & Affiliates

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Marston's plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

09-February-2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which:

 

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

7.375p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

15,605,242

2.46120%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

15,605,242

2.46120%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

7.375p ordinary

Purchase

1,043

GBP 0.989501

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

10-February-2021

Contact name:

Lionel Colaco

Telephone number*:

020 33956098

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETDKKBBQBKDDBD
Date   Source Headline
24th Jul 200912:46 pmRNSHolding(s) in Company
23rd Jul 20094:04 pmRNSTotal Voting Rights
23rd Jul 20093:10 pmRNSHolding(s) in Company
23rd Jul 200912:06 pmRNSDisclosure of Short Position
22nd Jul 20094:29 pmRNSHolding(s) in Company
22nd Jul 200912:30 pmRNSCompletion of Rights Issue and placing of rump
22nd Jul 20097:00 amRNSResult of Rights Issue
20th Jul 20091:23 pmRNSDisclosure of Short Position
17th Jul 20094:27 pmRNSHolding(s) in Company
17th Jul 20094:12 pmRNSDisclosure of Short Position
16th Jul 20094:20 pmRNSDisclosure of Short Position
16th Jul 20092:06 pmBUSDisclosure of Short Position
15th Jul 20093:38 pmRNSHolding(s) in Company
14th Jul 20097:00 amRNSDisclosure of Short Position
9th Jul 20095:29 pmRNSHolding(s) in Company- Replacement
9th Jul 200911:04 amRNSHolding(s) in Company
8th Jul 20093:28 pmRNSDisclosure of Short Position
6th Jul 20099:41 amRNSEGM Statement
3rd Jul 200911:30 amRNSDirector/PDMR Shareholding
3rd Jul 200911:27 amRNSDirector/PDMR Shareholding
1st Jul 20099:19 amRNSTotal Voting Rights
23rd Jun 20092:27 pmRNSDirector/PDMR Shareholding
18th Jun 20091:31 pmRNSPublication of Prospectus
18th Jun 20097:00 amRNSProposed Rights Issue
4th Jun 20099:56 amRNSHolding(s) in Company
29th May 200912:17 pmRNSTotal Voting Rights
28th May 200912:02 pmRNSDirector/PDMR Shareholding
22nd May 20097:00 amRNSHalf Yearly Report
30th Apr 200911:57 amRNSTotal Voting Rights
16th Apr 20094:50 pmRNSHolding(s) in Company
16th Apr 200910:15 amRNSHolding(s) in Company
15th Apr 20097:00 amRNSTrading Update
31st Mar 200911:29 amRNSTotal Voting Rights
31st Mar 200911:21 amRNSAppointment - Group Finance Director
5th Mar 20094:16 pmRNSDirector/PDMR Shareholding
27th Feb 20092:31 pmRNSTotal Voting Rights
25th Feb 20099:00 amRNSNotice of Trading Update
12th Feb 20099:30 amRNSAppointment of Group Finance Director
3rd Feb 200910:00 amRNSBoard Change
30th Jan 200911:05 amRNSTotal Voting Rights
28th Jan 20094:38 pmRNSDirector/PDMR Shareholding
27th Jan 200912:35 pmRNSHolding(s) in Company
23rd Jan 20094:05 pmRNSResult of AGM
23rd Jan 20097:00 amRNSAGM and Interim Management Statement
20th Jan 20093:39 pmRNSDirector/PDMR Shareholding
13th Jan 20097:00 amRNSFORMAL AGREEMENT ON BANK FACILITY EXTENSION
12th Jan 20093:01 pmRNSBlocklisting Interim Review
12th Jan 20092:29 pmRNSHolding(s) in Company
30th Dec 20083:07 pmRNSTotal Voting Rights
19th Dec 20084:24 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.